Regeneron convinces PTAB to review Novartis syringe patent

The US Patent Trial and Appeal Board (PTAB) has granted a review of a Novartis syringe patent following a challenge from biotech giant Regeneron.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

Invisalign maker secures first China win against clear aligner rival

13 August 2026 Clear aligner rivals are fighting over orthodontic technology across several major markets and the latest development in China has raised the stakes.

Regulation & Industry

Exclusive: ‘In the end, I did it my own way’ and became a UPC judge

12 August 2026 Unified Patent Court judge Margot Kokke has had an unconventional and oft-interrupted career as the “trailing spouse” of a diplomat. She talks to Sarah Speight about this and more in the fourth in a series of interviews with women judges at the court.

Pharma

Lilly mounts defence as generics circle Mounjaro and Zepbound

11 August 2026 A litigation campaign against generic drugmakers, including Sandoz, Hikma, and Amenal, raise the stakes in the fight over two of the world’s most lucrative weight loss and diabetes treatments.

More features

Invisalign maker secures first China win against clear aligner rival

Exclusive: ‘In the end, I did it my own way’ and became a UPC judge

Lilly mounts defence as generics circle Mounjaro and Zepbound

Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany

Kirkland clears conflicts hurdle in trade secrets spat

Former senior attorney-advisor to ITC commissioners joins Mintz

Novo’s Dutch win sends ‘clear message’ to unapproved semaglutide sellers

Brown Rudnick lands largest lateral IP team hire in firm history

Regeneron convinces PTAB to review Novartis syringe patent

More on this story

Editor's picks

Editor's picks

More features